Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
Jonathan Sitrin, Aaron M. Ring, K. Christopher García, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 6, pp. 1153-1165
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Regulatory T Cells and Human Disease
Shimon Sakaguchi, Norihisa Mikami, James B. Wing, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 541-566
Closed Access | Times Cited: 830
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski, Peng Li, Warren J. Leonard
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 648-659
Closed Access | Times Cited: 478
Homeostatic control of regulatory T cell diversity
Adrian Liston, Daniel H.D. Gray
Nature reviews. Immunology (2014) Vol. 14, Iss. 3, pp. 154-165
Closed Access | Times Cited: 408
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly, Róisín M. Loftus, Sinéad E. Keating, et al.
The Journal of Immunology (2014) Vol. 193, Iss. 9, pp. 4477-4484
Open Access | Times Cited: 406
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanová, Sarah Cooley, Todd E. DeFor, et al.
Blood (2014) Vol. 123, Iss. 25, pp. 3855-3863
Open Access | Times Cited: 385
CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets
Kate S. Smigiel, Elizabeth Richards, Shivani Srivastava, et al.
The Journal of Experimental Medicine (2013) Vol. 211, Iss. 1, pp. 121-136
Open Access | Times Cited: 364
Effect of tumor cells and tumor microenvironment on NK‐cell function
Massimo Vitale, Claudia Cantoni, Gabriella Pietra, et al.
European Journal of Immunology (2014) Vol. 44, Iss. 6, pp. 1582-1592
Open Access | Times Cited: 358
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu, Zhigang Tian, Haiming Wei
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 237
Functional interactions between innate lymphoid cells and adaptive immunity
Gregory F. Sonnenberg, Matthew R. Hepworth
Nature reviews. Immunology (2019) Vol. 19, Iss. 10, pp. 599-613
Open Access | Times Cited: 216
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Qianquan Ma, Wenyong Long, Changsheng Xing, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 198
Interactions between innate and adaptive lymphocytes
Georg Gasteiger, Alexander Y. Rudensky
Nature reviews. Immunology (2014) Vol. 14, Iss. 9, pp. 631-639
Open Access | Times Cited: 189
The meninges host a distinct compartment of regulatory T cells that preserves brain homeostasis
Miguel Marin-Rodero, Elisa Cintado, Alec J. Walker, et al.
Science Immunology (2025)
Closed Access | Times Cited: 2
IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Georg Gasteiger, Saskia Hemmers, Matthew A. Firth, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 6, pp. 1167-1178
Open Access | Times Cited: 193
Regulation of Mouse NK Cell Development and Function by Cytokines
Antoine Marçais, Sébastien Viel, Morgan Grau, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 159
Recognition and Regulation of T Cells by NK Cells
Katharina Pallmer, Annette Oxenius
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 151
Immune mechanisms in type 1 diabetes
Maja Wållberg, Anne Cooke
Trends in Immunology (2013) Vol. 34, Iss. 12, pp. 583-591
Closed Access | Times Cited: 146
PD-L1 blockade enhances anti-tumor efficacy of NK cells
Jeremiah L. Oyer, Sarah B. Gitto, Deborah A. Altomare, et al.
OncoImmunology (2018) Vol. 7, Iss. 11
Open Access | Times Cited: 132
Natural Killer Cells in Cancer Immunotherapy
Jeffrey S. Miller, Lewis L. Lanier
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 77-103
Open Access | Times Cited: 131
Lymph node – an organ for T‐cell activation and pathogen defense
Georg Gasteiger, Marco A. Ataide, Wolfgang Kastenmüller
Immunological Reviews (2016) Vol. 271, Iss. 1, pp. 200-220
Closed Access | Times Cited: 128
DNAM‐1 control of natural killer cells functions through nectin and nectin‐like proteins
Lucas Ferrari de Andrade, Mark J. Smyth, Ludovic Martinet
Immunology and Cell Biology (2013) Vol. 92, Iss. 3, pp. 237-244
Open Access | Times Cited: 127
T reg cells limit IFN-γ production to control macrophage accrual and phenotype during skeletal muscle regeneration
Marisella Panduro, Christophe Benoist, Diane Mathis
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 11
Open Access | Times Cited: 122
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
Jared E. Lopes, Jan L. Fisher, Heather Flick, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000673-e000673
Open Access | Times Cited: 113
Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
Sawa Ito, Catherine M. Bollard, Mattias Carlsten, et al.
Molecular Therapy (2014) Vol. 22, Iss. 7, pp. 1388-1395
Open Access | Times Cited: 108
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
Liliane Khoryati, Minh N. Pham, McKenna Sherve, et al.
Science Immunology (2020) Vol. 5, Iss. 50
Open Access | Times Cited: 103
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
Takeshi Ishikawa, Tetsuya Okayama, Naoyuki Sakamoto, et al.
International Journal of Cancer (2018) Vol. 142, Iss. 12, pp. 2599-2609
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top